Radical antegrade modular pancreatosplenectomy versus conventional left pancreatectomy for pancreatic cancer: study protocol for the multicentre randomized clinical RAMPS trial
BJS Open · 2025
DOI: 10.1093/bjsopen/zraf169 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift BJS Open, 2025. Verfasst von Magdalena Holze und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany. Hauptthemen laut MEDLINE: Pancreatectomy, Pancreatic Neoplasms, Splenectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Research Foundation DFG.
Abstract (Originalsprache)
Background
Complete surgical resection (R0 resection) is crucial for overall and disease-free survival in patients with pancreatic cancer undergoing curative surgery. The radical antegrade modular pancreatosplenectomy (RAMPS) procedure was developed to increase achievement of R0 resection margins for tumour resections of the pancreatic body and tail. By extending the posterior dissection plane, a more radical surgical resection can be achieved, as this is the most frequent site of positive margins in conventional left pancreatectomy. RAMPS includes a standardized lymph node dissection and early control of the splenic vessels. Feasibility and safety have already been demonstrated and retrospective studies have shown promising results regarding higher proportions of R0 resection and lymph node counts. To date, high-quality evidence from randomized clinical trials investigating the oncological benefit of RAMPS (that is, resection margin status, disease-free and overall survival) for this patient cohort is lacking.
Methods
The RAMPS trial is a multicentre, randomized clinical, patient and assessor-blinded, confirmatory, superiority trial. In all, 122 patients with an indication for left pancreatectomy due to malignancy of the pancreatic body or tail will be required in each study arm to achieve 80% power at a significance level of 0.025; patients will be randomized to either the RAMPS approach or conventional left pancreatectomy in a 1 : 1 ratio. Patients will be recruited over a 30-month enrolment period. The primary outcome will be the achievement of R0 resections. Secondary outcomes include survival and surgical, functional, and patient-reported outcomes with a 3-year follow-up.
Conclusion
The primary objective of the RAMPS trial is to demonstrate the superiority of the RAMPS approach over standard left pancreatectomy in improving the achievement of R0 resection and, consequently, long-term oncological patient outcomes. RAMPS could be established as the new surgical standard for tumour resection in patients with pancreatic cancer in the body or tail of the pancreas. Registration number: DRKS00033031 (https://www.bfarm.de/EN/BfArM/Tasks/German-Clinical-Trials-Register/_node.html).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, Heidelberg, Germany.
- Study Center of the German Society of Surgery, University Hospital Heidelberg, Heidelberg, Germany.
- Department of General, Visceral and Thoracic Surgery, Klinikum Nürnberg, Paracelsus Medical University Nuremberg, Nuremberg, Germany.
- Institute of Medical Biometry, University of Heidelberg, Heidelberg, Germany.
- Department for General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Surgery, Champalimaud Foundation, Lisbon, Portugal.
ORCID-Profile: Magdalena Holze, Rosa Klotz, Thilo Hackert, Felix J Hüttner
Förderung
- German Research Foundation DFG
Zitieren
APA
Holze, M., Pianka, F., Wittmann, M., Photiadis, I., Tenckhoff, S., Sander, A., Balzer, A., Klose, C., Klotz, R., Al-Saeedi, M., Loos, M., Michalski, C. W., Hackert, T., Heger, P., Diener, M. K., Büchler, M. W., & Hüttner, F. J. (2025). Radical antegrade modular pancreatosplenectomy versus conventional left pancreatectomy for pancreatic cancer: study protocol for the multicentre randomized clinical RAMPS trial. BJS Open. https://doi.org/10.1093/bjsopen/zraf169
Vancouver
Holze M, Pianka F, Wittmann M, Photiadis I, Tenckhoff S, Sander A, et al. Radical antegrade modular pancreatosplenectomy versus conventional left pancreatectomy for pancreatic cancer: study protocol for the multicentre randomized clinical RAMPS trial. BJS Open. 2025. doi:10.1093/bjsopen/zraf169
BibTeX
@article{Holze2025,
author = {Holze, Magdalena and Pianka, Frank and Wittmann, Martin and Photiadis, Ines and Tenckhoff, Solveig and Sander, Anja and Balzer, Alexandra and Klose, Christina and Klotz, Rosa and Al-Saeedi, Mohammed and Loos, Martin and Michalski, Christoph W and Hackert, Thilo and Heger, Patrick and Diener, Markus K and Büchler, Markus W and Hüttner, Felix J},
title = {Radical antegrade modular pancreatosplenectomy versus conventional left pancreatectomy for pancreatic cancer: study protocol for the multicentre randomized clinical RAMPS trial},
journal = {BJS Open},
year = {2025},
doi = {10.1093/bjsopen/zraf169}
}
EUVIMED